Share page on LinkedIn


Board of Directors

The Board of Directors of ICON plc is made up of a diverse range of professionals who are experts in their fields and the majority are independent (10 out of 12 directors were determined to be independent as at 31 December 2021 in accordance with NASDAQ rules and 4 out of twelve directors are female). Each provide valuable skills, knowledge and experience and make important contributionto the working of the Board. Further information on the experience, qualifications and industry knowledge of the Directors is available from the Annual Report and/or Form 20-F as well as details of current committee composition.

Ethics and compliance

We are committed to our core values of Accountability & Delivery, Collaboration, Partnership and Integrity in everything we do. Meeting these values requires us all to work to the highest ethical standards and demonstrate a commitment to honesty, transparency and quality. This is embedded in our Global Code of Ethical Conduct which addresses the core principles underpinning the behaviour required of ICON and our people in our internal interactions with each other and our external dealings with patients, customers, health care professionals, regulators, investors, vendors and other third parties.

Highlights of ICON’s Ethics and Compliance programme include:

  • Setting standards of conduct in written and accessible company policies and procedures
  • Raising awareness through training and regular internal and external communications
  • Ensuring there are avenues to ask questions or raise concerns, including our confidential, externally hosted Ethics Line available 24/7
  • Conducting or monitoring investigations of reported noncompliance  in the risk areas under its oversight


ICON is committed to responsible, sustainable and ethical business practices and we are committed to working with only those who embrace high standards of behavior consistent with our own. We manage our suppliers through our Global Procurement department and the on-boarding of new suppliers is completed through a centrally managed due diligence process. We require our suppliers to abide by our Global Supplier Code of Conduct.



ICON is committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities. Quality is the cornerstone of our success. The quality of our work is vital to our mission of bringing better medications to patients around the world. We are committed to maintaining, supporting, checking and improving our quality systems to exceed the quality standards demanded by our clients, patients and regulatory authorities.

Find out more